Skip to main content
Premium Trial:

Request an Annual Quote

IBM, NetGenics Partner in Deploying DiscoveryLink

Premium

WHITE PLAINS, NY--IBM announced that it has launched DiscoveryLink, a combination of middleware and integration services that it said will speed product cycles and reduce development costs for agriscience, biotechnology, and pharmaceutical companies. DiscoveryLink is the first product of IBM’s newly formed life sciences organization.

To deploy the product, IBM will team with software provider NetGenics of Cleveland, Ohio. Daniel McCurdy, vice-president, IBM life sciences, said, "By combining our expertise in database and IT infrastructure with NetGenics’ knowledge of industry applications, we can deliver a solution that we expect will dramatically impact the industry’s productivity."

IBM said the package, which will be available first quarter 2000, will create a virtual database by allowing data to be accessed by an application program as if they were in a single database, and in a single format, even though they remain heterogeneous in format and decentralized.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.